Clinical Trials to Treat Thymoma and Thymic Carcinoma

Trials 1-10 of 10

A Study of Intensity-Modulated Pleural Radiation Therapy in People with Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
Status: Active
Location: 7 locations
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Status: Active
Location: 3 locations
Pembrolizumab and Sunitinib Malate in Treating Participants with Refractory Metastatic or Unresectable Thymic Cancer
Status: Active
Location: 3 locations
Sacituzumab Govitecan-Hziy for the Treatment of Patients with Advanced Thymoma or Thymic Carcinoma
Status: Active
Location: 2 locations
PT-112 in Subjects With Thymoma and Thymic Carcinoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Ivonescimab for the Treatment of Thymic Cancer
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Pembrolizumab in Treating Participants with Unresectable Thymoma or Thymic Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
The Cardiac Radiation Therapy Sparing for Thoracic Cancers, HEARTS Trial
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin